Skip to main content
TipRanks
Go Ultimate75% OFF

Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Report

1,946 Followers

JAZZ Q2 2026 EPS Results

Actual EPS
$5.71
Consensus EPS
$6.18
Beat/Miss
Missed by -$0.46
One Year Ago EPS
-$8.25

JAZZ Q2 2026 Revenue Results

Actual Revenue
$1.21B
Expected Revenue
$1.11B
Beat/Miss
Beat by +$93.87M
YoY Revenue Growth
+15.55%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/03/2026
Time
After Close
Conference Call
Monday, August 3, 2026
JAZZ Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

JAZZ Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

JAZZ Earnings History

JAZZ earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)6.96-6.64――
Nov 02, 20262026 (Q3)-4.03-3.888.13-147.72% (-12.01)
Aug 03, 20262026 (Q2)6.175.71-8.25169.21% (+13.96)
May 05, 20262026 (Q1)4.646.341.68277.38% (+4.66)
Feb 24, 20262025 (Q4)6.526.646.60.61% (+0.04)
Nov 05, 20252025 (Q3)5.958.136.6123.00% (+1.52)
Aug 05, 20252025 (Q2)-7.61-8.255.3-255.66% (-13.55)
May 06, 20252025 (Q1)4.661.682.68-37.31% (-1.00)
Feb 25, 20252024 (Q4)5.866.605.0231.47% (+1.58)
Nov 06, 20242024 (Q3)5.506.614.8436.57% (+1.77)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed